These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24338510)
1. Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo. Xie BH; Yang JY; Li HP; Zhang B; Chen W; Zhou B; Peng BG; Liang LJ; He Q Clin Transl Oncol; 2014 Aug; 16(8):753-60. PubMed ID: 24338510 [TBL] [Abstract][Full Text] [Related]
2. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma. Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511 [TBL] [Abstract][Full Text] [Related]
3. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study. El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725 [TBL] [Abstract][Full Text] [Related]
4. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA. Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793 [TBL] [Abstract][Full Text] [Related]
5. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297 [TBL] [Abstract][Full Text] [Related]
6. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma]. Gao J; Chen M; Peng ML; Ren H Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555 [TBL] [Abstract][Full Text] [Related]
7. Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA. Peng BG; He Q; Liang LI; Xie BH; Hua YP; Chen ZB; Zhou F Br J Biomed Sci; 2006; 63(3):123-8. PubMed ID: 17058712 [TBL] [Abstract][Full Text] [Related]
8. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer. Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429 [TBL] [Abstract][Full Text] [Related]
9. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Nair SK; Morse M; Boczkowski D; Cumming RI; Vasovic L; Gilboa E; Lyerly HK Ann Surg; 2002 Apr; 235(4):540-9. PubMed ID: 11923611 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma. Su H; Li B; Zheng L; Wang H; Zhang L Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma. Zhang Y; Xie F; Yin Y; Zhang Q; Jin H; Wu Y; Pang L; Li J; Gao J Int J Nanomedicine; 2021; 16():1553-1564. PubMed ID: 33658783 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes. Wang XH; Qin Y; Hu MH; Xie Y Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645 [TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma. Chen Y; Huang A; Gao M; Yan Y; Zhang W Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111 [TBL] [Abstract][Full Text] [Related]
15. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study. El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618 [TBL] [Abstract][Full Text] [Related]
17. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells. Gao L; Fan HH; Lu HZ; Nie XX; Liu Y; Yang YM; Qian KC; Gao F Transfusion; 2007 Feb; 47(2):256-65. PubMed ID: 17302772 [TBL] [Abstract][Full Text] [Related]
18. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401 [TBL] [Abstract][Full Text] [Related]
19. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy. Han Y; Wu Y; Yang C; Huang J; Guo Y; Liu L; Chen P; Wu D; Liu J; Li J; Zhou X; Hou J J Transl Med; 2017 Mar; 15(1):64. PubMed ID: 28330473 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma. Sun K; Wang L; Zhang Y Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]